Kevin L. Law

596 total citations
11 papers, 444 citations indexed

About

Kevin L. Law is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Kevin L. Law has authored 11 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Kevin L. Law's work include Drug Transport and Resistance Mechanisms (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Cancer therapeutics and mechanisms (2 papers). Kevin L. Law is often cited by papers focused on Drug Transport and Resistance Mechanisms (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Cancer therapeutics and mechanisms (2 papers). Kevin L. Law collaborates with scholars based in United States. Kevin L. Law's co-authors include James J. Starling, Anne H. Dantzig, Bryan H. Norman, Stephen D. Mikolajczyk, Damon L. Meyer, Louis N. Jungheim, Joseph M. Gruber, Julian S. Kroin, Linda B. Tabas and Timothy A. Shepherd and has published in prestigious journals such as Journal of Medicinal Chemistry, Archives of Biochemistry and Biophysics and Bioconjugate Chemistry.

In The Last Decade

Kevin L. Law

11 papers receiving 427 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin L. Law United States	11	233	224	99	75	70	11	444
Ellen C. Spoelstra Netherlands	7	270 1.2×	225 1.0×	29 0.3×	18 0.2×	103 1.5×	7	411
Paul L. Chello United States	17	140 0.6×	395 1.8×	85 0.9×	24 0.3×	40 0.6×	30	695
Hennie M.M. Schlüper Netherlands	13	218 0.9×	231 1.0×	58 0.6×	74 1.0×	14 0.2×	19	466
Federica Bucci Italy	14	168 0.7×	428 1.9×	121 1.2×	31 0.4×	9 0.1×	18	622
Regina Tugyi Hungary	5	94 0.4×	237 1.1×	51 0.5×	53 0.7×	22 0.3×	6	344
Wendy Dangerfield New Zealand	7	419 1.8×	366 1.6×	292 2.9×	13 0.2×	139 2.0×	7	805
Gwan Sun Lee South Korea	13	238 1.0×	311 1.4×	204 2.1×	30 0.4×	26 0.4×	21	595
Adrian Folkes United Kingdom	7	163 0.7×	207 0.9×	164 1.7×	9 0.1×	54 0.8×	11	438
Franciska J. Koopman Netherlands	7	301 1.3×	140 0.6×	45 0.5×	23 0.3×	77 1.1×	9	537
Chiho Ono Japan	14	199 0.9×	169 0.8×	33 0.3×	44 0.6×	37 0.5×	29	522

Countries citing papers authored by Kevin L. Law

Since Specialization

Citations

This map shows the geographic impact of Kevin L. Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin L. Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin L. Law more than expected).

Fields of papers citing papers by Kevin L. Law

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin L. Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin L. Law. The network helps show where Kevin L. Law may publish in the future.

Co-authorship network of co-authors of Kevin L. Law

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin L. Law. A scholar is included among the top collaborators of Kevin L. Law based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin L. Law. Kevin L. Law is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Bender, David M., Jingqi Bao, Anne H. Dantzig, et al.. (2009). Synthesis, Crystallization, and Biological Evaluation of an Orally Active Prodrug of Gemcitabine. Journal of Medicinal Chemistry. 52(22). 6958–6961. 94 indexed citations

Norman, Bryan H., Peter A. Lander, Joseph M. Gruber, et al.. (2005). Cyclohexyl-linked tricyclic isoxazoles are potent and selective modulators of the multidrug resistance protein (MRP1). Bioorganic & Medicinal Chemistry Letters. 15(24). 5526–5530. 49 indexed citations

Norman, Bryan H., Joseph M. Gruber, Sean P. Hollinshead, et al.. (2002). Tricyclic isoxazoles are novel inhibitors of the multidrug resistance protein (MRP1). Bioorganic & Medicinal Chemistry Letters. 12(6). 883–886. 55 indexed citations

Norman, Bryan H., Anne H. Dantzig, Julian S. Kroin, et al.. (1999). Reversal of resistance in multidrug resistance protein (MRP1)-overexpressing cells by LY329146. Bioorganic & Medicinal Chemistry Letters. 9(23). 3381–3386. 23 indexed citations

Starling, James J., Robert L. Shepard, Jin Cao, et al.. (1997). Pharmacological characterization of LY335979: A potent cyclopropyldibenzosuberane modulator of P-glycoprotein. Advances in Enzyme Regulation. 37. 335–347. 70 indexed citations

Patel, Vinod F., et al.. (1996). Novel Acid Labile COL1 Trityl-Linked Difluoronucleoside Immunoconjugates: Synthesis, Characterization, and Biological Activity¹. Bioconjugate Chemistry. 7(4). 497–510. 30 indexed citations

Mikolajczyk, Stephen D., et al.. (1996). Dextran Modification of a Fab‘−β-Lactamase Conjugate Modulated by Variable Pretreatment of Fab‘ with Amine-Blocking Reagents. Bioconjugate Chemistry. 7(1). 150–158. 12 indexed citations

Meyer, Damon L., Kevin L. Law, Janice K. Payne, et al.. (1995). Site-Specific Prodrug Activation by Antibody-.beta.-Lactamase Conjugates: Preclinical Investigation of the Efficacy and Toxicity of Doxorubicin Delivered by Antibody Directed Catalysis. Bioconjugate Chemistry. 6(4). 440–446. 25 indexed citations

Mikolajczyk, Stephen D., Damon L. Meyer, James J. Starling, et al.. (1994). High Yield, Site-Specific Coupling of N-Terminally Modified .beta.-Lactamase to a Proteolytically Derived Single-Sulfhydryl Murine Fab'. Bioconjugate Chemistry. 5(6). 636–646. 26 indexed citations

10.

Meyer, Damon L., Louis N. Jungheim, Kevin L. Law, et al.. (1993). Site-specific prodrug activation by antibody-beta-lactamase conjugates: regression and long-term growth inhibition of human colon carcinoma xenograft models.. PubMed. 53(17). 3956–63. 49 indexed citations

11.

Law, Kevin L. & David F. Smith. (1987). III6NeuAcLc4Cer in human SW1116 colorectal carcinoma cells: A possible oncofetal antigen that is not dependent on Lewis gene expression. Archives of Biochemistry and Biophysics. 258(2). 315–323. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact